Dow Up 0.08% Nasdaq Down 0.30%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.77 Down 0.12(2.45%) Sep 19, 4:15PM EDT
|After Hours : 4.76 Down 0.01 (0.21%) Sep 19, 7:45PM EDT
Prev Close:4.89
Open:4.90
Bid:4.73 x 1000
Ask:4.76 x 3600
1y Target Est:11.00
Beta:1.61
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.64 - 4.90
52wk Range:4.50 - 7.82
Volume:5,731,411
Avg Vol (3m):3,660,280
Market Cap:584.49M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 2.45%584.49M
ABTDown 0.23%65.55B
GSKUp 0.19%113.81B
RHHBYDown 0.70%255.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):174.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback